| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S424-829
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S436-829 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-51
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6891 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-42 |
| filingDate |
1997-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate |
2000-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2000511513-A |
| titleOfInvention |
Prodrug composition and drug delivery method using synthetic receptor |
| abstract |
(57) [Summary]nThe present invention relates to prodrug conjugates and multi-prodrugs comprising a drug specifically bound to a synthetic receptor in such a way that the active drug is only available in the presence of the targeted pathophysiological receptor. Provide a drug complex. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2009116557-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-WO2009144927-A1 |
| priorityDate |
1996-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |